StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report issued on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance Shares of NASDAQ MNOV opened at $1.43 on Monday. The stock has a market cap of $70.14 million, a price-to-earnings ratio of -8.41 and […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: Prudential Financial, Inc. (NYSE:PRU) Major Shareholder Purchases $18,000,011.88 in Stock
Next post Howie Carr: Trump vs. Biden and CNN